Skip to main content
. Author manuscript; available in PMC: 2022 Mar 10.
Published in final edited form as: Horm Res Paediatr. 2021 Mar 10;93(11-12):609–615. doi: 10.1159/000514130

Table 2.

Disease-specific Factors and Adiposity Rebound in Youth with CAH

Disease-specific Factors Mean ± SD r p
17-hydroxyprogesterone at diagnosis (nmol/L) 951.6 ± 1182.4 −0.15 0.4
Average Bone Age SD 1.8 ± 2.2 −0.39 0.01
Average Hydrocortisone Dose (one year before age at AR; mg/m2/day) 16.0 ± 7.1 −0.13 0.4
Average Fludrocortisone Dose (one year before age at AR; mg/day) 0.1 ± 0.03 0.31 0.04

AR, adiposity rebound